SOLACI Office

OFFICES

Meeting Planner
Carolina Pallavicini
Sessions Secretariat
Laura Stura
Communications
Juan Ventura
Administration
Flavia de Luca
ProEducar Project Secretary
Marisa Desiervi
 Research Secretary
 Mónica Buus

CONGRESS

President of SOLACI-CACI 2020 Congress, Buenos Aires, Argentina.
Dr. Aníbal Damonte
Scientific Comitee President | SOLACI-CACI 2020, Buenos Aires, Argentina.
Dr. Alfredo E. Rodríguez
General Coordinator
Carolina Pallavicini
 

PROEDUCAR

Director
Dr. Gabriel Maluenda, Dr. Leandro I. Lasave
Educational Newsletter Director
Dr. Gustavo Pedernera
Fellow Course Director
Dr. Leandro I. Lasave
Fellow’s Corner Director
Dr. Nicolás Zaderenko
Project Secretary
Marisa Desiervi
 

SESSIONS

Director
Dr. Gustavo Vignolo
Vice-Director
Dr. Marcio Montenegro
Scientific Committee Director
Dr. Ricardo Coloma
Secretariat
Laura Stura
 

SOLACI RESEARCH

Director
Dr. Pablo Lamelas
Secretariat
Mónica Buus
 

SOLACI PERIPHERAL

Director
Dr. Maurício Cavalieri Machado
 

SOL SOLACI PROGRAM

Director
Dr. Marcelo Halac
Vice-Director
Dr. Erick Hórnez
Scientific Committee Director
Dr. Raúl Arrieta
 

SOLACI MIL GROUP

Director
Dr. Carla Agatiello
 

WEB

Director
Dr. José A. G. Álvarez
Editor
Dr. Gaspar Caponi
Editorial Council
Dr. Andrés Rodríguez
Dr. Carlos Fava
Dr. Omar Tupayachi
Dr. Alejandro Goldsmit
 

CONTACT

Sociedad Latinoamericana de Cardiología Intervencionista
Adolfo Alsina 2653 Piso 2° H – CP C1090AAQ
Ciudad Autónoma de Buenos Aires
Tel. | Fax: (+5411) 4954-7173
Correo electrónico: info@solaci.org
www.solaci.org

Previous article
Next article

More articles by this author

Registration Open for Module 2 of the 2026 Annual Course: Multislice CT and Cardiovascular Magnetic Resonance Imaging

The Latin American Society of Interventional Cardiology (SOLACI) and the Argentine College of Interventional Cardioangiologists (CACI) announce the opening of registration for Module 2...

EuroPCR 2026 | Is localized anticoagulation the next step for coronary stents?

The DESyne BDS Plus stent was developed as a thin-strut, bioabsorbable polymer drug-eluting stent that combines sirolimus release with two anticoagulant agents (rivaroxaban and...

Esta es una entrada en ingles

demo en ingles

test eng

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...